These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 22318789

  • 1. ADHD pharmacotherapy: rates of stimulant use and cardiovascular risk.
    Kratochvil CJ.
    Am J Psychiatry; 2012 Feb; 169(2):112-4. PubMed ID: 22318789
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Encouraging news about ADHD drugs and heart risk in adults.
    Harv Ment Health Lett; 2012 Mar; 28(9):7. PubMed ID: 22474711
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular effects of methylphenidate.
    Daniels SR.
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder.
    Silva RR, Skimming JW, Muniz R.
    Clin Pediatr (Phila); 2010 Sep; 49(9):840-51. PubMed ID: 20693523
    [Abstract] [Full Text] [Related]

  • 7. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.
    Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC.
    J Am Acad Child Adolesc Psychiatry; 2012 Feb; 51(2):147-56. PubMed ID: 22265361
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects.
    Rapport MD, Moffitt C.
    Clin Psychol Rev; 2002 Nov; 22(8):1107-31. PubMed ID: 12436807
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Supraventricular tachycardia in an adolescent with attention-deficit/hyperactivity disorder (ADHD).
    Hammerness PG, Wilens TE, Berul CI, Elkort MS.
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):219-220. PubMed ID: 18216716
    [No Abstract] [Full Text] [Related]

  • 14. Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason.
    Batra AS, Alexander ME, Silka MJ.
    Pediatr Cardiol; 2012 Mar; 33(3):394-401. PubMed ID: 22298228
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of stimulant medications for ADHD.
    Natl Bur Econ Res Bull Aging Health; 2014 Mar; (1):1-2. PubMed ID: 25141389
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Safety of drugs to treat attention deficit disorder with hyperactivity].
    Péluchon R.
    Soins Pediatr Pueric; 2012 Mar; (268):9. PubMed ID: 23074795
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.